Ultragenyx Pharmaceutical Inc. (RARE) Stock Price, Quote & AI Analysis
Live RARE stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Ultragenyx Pharmaceutical Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Ultragenyx Pharmaceutical Inc. (RARE), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Ultragenyx Pharmaceutical Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Ultragenyx Pharmaceutical Inc. Overview
Company information
Company Overview
Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Ultragenyx Pharmaceutical Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...